期刊文献+

冠心病患者治疗前后血浆白细胞介素-6水平的变化 被引量:2

Changes of Plasma Levels of Cytokine Interleukin 6 in Patients before and after the Treatment for AMI and CSA
暂未订购
导出
摘要 目的 :检测白细胞介素 6 (IL 6 )在急性心肌梗死 (AMI)及心绞痛 (CSA)发病中的变化。方法 :用双抗体夹心酶联免疫吸附法 (ELISA) ,对 2 7例AMI、2 0例CSA(1 1例不稳定型心绞痛与 9例稳定型心绞痛 )患者及 31名健康人血浆中IL 6含量进行测定。结果 :AMI患者血浆中IL 6含量明显升高 ,与健康人比较有显著性差异 (P<0 0 1 ) ,治疗前后无显著性差异 (P >0 0 5 )。不稳定型心绞痛 (UA)患者血浆中IL 6含量明显升高 (P <0 0 5 ) ,在稳定型心绞痛 (SA)患者血浆中含量无显著性变化 (P >0 0 5 ) ,IL 6在UA中的含量高于SA ,有显著性差异 (P<0 0 5 ) ,AMI与UA相比有非常显著性差异 (P <0 0 1 ) ,在AMI中的含量高于UA。结论 :IL 6参与了AMI和CSA的发病。 Objective: To study the role of interleukin 6 (IL 6) in the pathophysiological process of acute myocardial infarction (AMI) and coronary spastic angina (CSA). Methods: The plasma IL 6 levels in 27 cases of AMI, and 20 cases of CSA including 11 cases of unstable angina (UA) and 9 cases of stable angina (SA), were measured with enzyme linked immunosorbent assay (ELISA), before and after treatment for their diseases. The plasma IL 6 levels of 31 healthy people were measured as control. Results: The IL 6 levels were higher in AMI patients than those in healthy controls( P<0 01 ). IL 6 levels in AMI patients before and after treatment did not show difference( P>0 05 ). For CSA patients, the IL 6 level was higher in UA than in healthy controls( P<0 05 ). but it’s not different in SA from that in healthy people( P>0 05 ). The IL 6 levels were higher in UA than in SA( P<0 05 ). And they were higher in AMI than in UA( P<0 01 ). Conclusion: The results suggest that the levels of IL 6 significantly relate to the pathogenesis of AMI and CSA.[
出处 《贵阳医学院学报》 CAS 2004年第1期28-30,共3页 Journal of Guiyang Medical College
关键词 心肌梗塞 心绞痛 白细胞介素-6 acute myocardial infarction angina pectoris interleukin 6
  • 相关文献

参考文献10

  • 1周同,宋长玲.细胞粘附分子与心血管疾病[J].中国循环杂志,1995,10(8):502-504. 被引量:16
  • 2张炳勇,张善亮,伍学强,张建军,张文武,马改风.急性心肌梗塞患者肿瘤坏死因子和白细胞介素6水平的研究[J].中国危重病急救医学,1996,8(5):276-277. 被引量:5
  • 3叶任高.内科学[M]:第5版[M].北京:人民卫生出版社,2001.159.
  • 4Song YG,Know HM,Kim JM,et al.Serologic and histopagthologic study of chlamydia pnenumoniae infection in atherosclerosis:a possible pathogene machanism of atherosclerosis induced by chamydis penumoniae[J].Yonsei Med J,2000,41(3):319-327.
  • 5Miyao Y,Yasue H,Ogawe H,et al.Elevated plasma IL-6 levels in patients with acute myocardial infarction[J].Am Heart J,1993,126(4):1 299-1 303.
  • 6Mazzone A,Servi SD,Ricevui G,et al.Increased expression of neutroph and monocyte adhesion molecules in unstable coronary artery disease[J].Circulation,1993,88(2):358-363.
  • 7Ikeda U,Ohkawa F,Seino Y,et al.Serum interleukin 6 levels become elevated in acute myocardial infarction[J].J Mol Cell Cardiol,1992,24(6):579-840.
  • 8Moreno PR,Falk E,Palacios IF,et al.Macrophage infiltration in acute coronary syndromes:Implications for plague ruptre[J].Circulation,1994,90(2):775-778.
  • 9Cruickshank AM,Oldroyde K,Cobbe S,et al.Serum IL-6 in suspected myocardial infarction[J].Lancet,1994,343(8 904):974-975.
  • 10Odeh M.Tumor necrosis factor-α as a myocardial depression substance[J].J Cardiol,1993,42:231.

共引文献97

同被引文献16

  • 1赵翠花,王治中,程冠昌,何瑞利,张媛.急性心肌梗死患者血内皮素-1与高敏C-反应蛋白的动态变化[J].第三军医大学学报,2006,28(15):1604-1604. 被引量:7
  • 2谢健敏,吴素琴.脑钠素与急性心肌梗死预后关系[J].中国基层医药,2006,13(9):1487-1488. 被引量:3
  • 3苏汉文,李栋,李艳.急性心肌梗死血清标志物临床应用的比较[J].四川医学,2006,27(11):1125-1127. 被引量:4
  • 4高卫红,周明先,李光真.脂肪酸结合蛋白和糖原磷酸化酶同工酶BB对急性心肌梗死早期诊断的价值[J].实用临床医药杂志,2006,10(6):95-95. 被引量:1
  • 5Hopkins W E, Chen Z, Fukagawa N K, et al. Increased atrial and brain natriuretic peptides in adults with congebital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion[J ]. Circulation, 2004, 109: 2872.
  • 6Mair J, Hammererlereher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure[J]. Clin Chem Lab Med, 2001, 39: 571.
  • 7Gill D, Seidier T, Troughton R W, et al. Vigorous response in plasma N-terminal pro-brain natriuretic peptide(NT-proB- NP) to acute myocardial infarction [J]. Clin Sci (lond), 2004, 106: 135.
  • 8Junnichi I, Wei C, Fu mihikok, et al. Prognostic value of combination of cardiac troponint and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure[J]. Clin Chem, 2003, 49(12): 2020.
  • 9Sabatine M, Morrow D, de Lemos J, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reative protein, and B-type natriuretic peptide [ J ]. Circulation, 2002, 105: 1760.
  • 10Karabulut A, Kaplan A, Asian C, et al. The association between NT-proBNP levels, fuctional capacity and stage in patients with heart failure[J]. Acta Cardiol, 2005, 60: 631.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部